InvestorsHub Logo
Followers 51
Posts 9104
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 06/23/2022 11:20:24 PM

Thursday, June 23, 2022 11:20:24 PM

Post# of 13480
MRNA manufacturing variant vaccine ahead of regulatory approval shows a lot of confidence they will get contracts from many countries. Again, the company has the capability to mass produce and is creating a moat by having a physical presence in key countries. Cannot emphasize enough that manufacturing and distributing is key and Moderna has the dollars to invest in this.

This is at least another 50 billion sales!!!!!!!!


Moderna's COVID-19 variant vaccine will be ready to ship in August as the company has been making shots ahead of approval, Chief Executive Stephane Bancel told Reuters on Wednesday, adding that the only bottleneck to supply was a regulatory one.

"Our goal is as early as August given we're going to file all the data in June, by the end of June... hopefully in the August timeframe, the vaccine is authorised," Bancel said in an interview.

"We can start shipping in the August timeframe. Some countries might be September, but that will really be a regulatory decision. Because what is (the) bottleneck now is regulatory. From a manufacturing standpoint, we are making the vaccine."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News